The potential of CpG-enhanced plasmid DNA vectors encoding a truncated secreted form of bovine herpesvirus-1 (BHV-1) glycoprotein D (tgD) to induce enhanced immune responses in cattle was investigated. We created tgD expression plasmids containing 0, 40 or 88 copies of the hexamer 5’ GTCGTT 3’, a known pan-activating CpG motif in several species. The total tgD-specific IgG titre of calves immunized with these plasmids did not correlate with the CpG content of the plasmid backbone. However, the pBISIA88-tgD-vaccinated group showed a significantly lower IgG1:IgG2 ratio than calves immunized with pBISIA40-tgD or pMASIA-tgD, which has no CpG motifs inserted. Antigen-specific lymphocyte proliferation and IFN-γ secretion by peripheral blood mononuclear cells correlated positively with the CpG content of the vectors. In contrast, calves that received a killed BHV-1 vaccine had an IgG1-predominant isotype and low lymphocyte proliferation and IFN-γ levels. Following challenge, the pBISIA88-tgD-immunized group developed the greatest anamnestic response, the highest BHV-1 neutralization titres in serum and a significantly lower level of virus shedding than the saline control group. However, there were no significant differences in clinical symptoms of infection between the DNA-immunized groups and the saline control group. These data indicate that CpG-enhanced plasmids induce augmented immune responses and could be used to vaccinate against pathogens requiring a strong cellular response for protection.
BabiukL. A.,
L’ItalienJ.,
van Drunen Littel-van den HurkS.,
ZambT.,
LawmanJ. P.,
HughesG.,
GiffordG. A.1987; Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159:57–66
BabiukL. A.,
LewisP. J.,
CoxG.,
van Drunen Littel-van den HurkS.,
Baca-EstradaM.,
TikooS. K.1995; DNA immunization with bovine herpesvirus-1 genes. Annals of the New York Academy of Sciences 772:47–63
BabiukL. A.,
LewisP. J.,
van Drunen Littel-van den HurkS.,
TikooS.,
LiangX.1998; Nucleic acid vaccines: veterinary applications. Current Topics in Microbiology and Immunology 226:90–106
BraunR.,
BabiukL.,
van Drunen Littel-van den HurkS.1997; Enhanced immune response to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vaccine Research 6:151–164
BraunR. P.,
BabiukL. A.,
LoehrB. I.,
van Drunen Littel-van den HurkS.1999; Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology 265:46–56
BrownW. C.,
EstesD. M.,
ChantlerS. E.,
KegerreisK. A.,
SuarezC. E.1998; DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells. Infection and Immunity 66:5423–5432
CottenM.,
BakerA.,
SaltikM.,
WagnerE.,
BuschleM.1994; Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Therapy 1:239–246
HarlandR. J.,
PotterA. A.,
van Drunen Littel-van den HurkS.,
van DonkersgoedJ.,
ParkerM. D.,
ZambT. J.,
JanzenE. D.1992; The effect of subunit or modified live herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Canadian Veterinary Journal 33:734–741
KlinmanD. M.,
IshiiK. J.,
VerthelyiD.2000; CpG DNA augments the immunogenicity of plasmid DNA vaccines. Current Topics in Microbiology and Immunology 247:131–142
KriegA. M.,
YiA. K.,
MatsonS.,
WaldschmidtT. J.,
BishopG. A.,
TeasdaleR.,
KoretzkyG. A.,
KlinmanD. M.1995; CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549
KriegA. M.,
WuT.,
WeeratnaR.,
EflerS. M.,
Love-HomanL.,
YangL.,
YiA. K.,
ShortD.,
DavisH. L.1998a; Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proceedings of the National Academy of Sciences, USA 95:12631–12636
LoehrB. I.,
WillsonP.,
BabiukL. A.,
van Drunen Littel-van den HurkS.2000; Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. Journal of Virology 74:6077–6086
LoehrB. I.,
PontarolloR.,
RankinR.,
LatimerL.,
WillsonP.,
BabiukL. A.,
van Drunen Littel-van den HurkS.2001a; Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. Journal of General Virology 82:3035–3043
LoehrB. I.,
RankinR.,
PontarolloR.,
KingT.,
WillsonP.,
BabiukL. A.,
van Drunen Littel-van den HurkS.2001b; Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle. Virology 289:327–333
PontarolloR. A.,
RankinR.,
BabiukL. A.,
GodsonD. L.,
GriebelP. J.,
HeckerR.,
KriegA. M.,
van Drunen Littel-van den HurkS.2002; Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Veterinary Immunology and Immunopathology 84:43–59
RaggoC.,
HabermehlM.,
BabiukL. A.,
GriebelP.2000; The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-γ. Journal of General Virology 81:2665–2673
RankinR.,
PontarolloR.,
IoannouX.,
KriegA. M.,
HeckerR.,
BabiukL. A.,
van Drunen Littel-van den HurkS.2001; CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense and Nucleic Acid Drug Development 11:333–340
RankinR.,
PontarolloR.,
GomisS.,
KarvonenB.,
WillsonP.,
LoehrB. I.,
GodsonD. L.,
BabiukL. A.,
HeckerR.,
van Drunen Littel-van den HurkS.2002; CpG-containing oligodeoxynucleotides augment and switch the immune response of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20:3014–3022
RhodesS. G.,
CocksedgeJ. M.,
CollinsR. A.,
MorrisonW. I.1999; Differential cytokine responses of CD4+ and CD8+ T cells in response to bovine viral diarrhoea virus in cattle. Journal of General Virology 80:1673–1679
RoyM. J.,
WuM. S.,
BarrL. J.,
FullerJ. T.,
TusseyL. G.,
SpellerS.,
CulpJ.,
BurkholderJ. K.,
SwainW. F.,
DixonR. M.,
WideraG.,
VesseyR.,
KingA.,
OggG.,
GallimoreA.,
HaynesJ. R.,
Heydenburg FullerD.2000; Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764–778
SchnareM.,
HoltA. C.,
TakedaK.,
AkiraS.,
MedzhitovR.2000; Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Current Biology 10:1139–1142
ShodaL. K.,
KegerreisK. A.,
SuarezC. E.,
MwangiW.,
KnowlesD. P.,
BrownW. C.2001; Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages. Journal of Leukocyte Biology 70:103–112
TaylorG.,
ThomasL. H.,
WyldS. G.,
FurzeJ.,
SoppP.,
HowardC. J.1995; Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. Journal of Virology 69:6658–6664
UwieraR. R. E.,
RankinR.,
AdamsG. P.,
PontarolloR. A.,
van Drunen Littel-van den HurkS.,
MiddletonD. M.,
BabiukL. A.,
GriebelP. J.2001a; Effects of intradermally administered plasmid deoxyribonucleic acid on ovine popliteal lymph node morphology. Anatomical Record 262:186–192
UwieraR. R. E.,
GerdtsV.,
PontarolloR. A.,
BabiukL. A.,
MiddletonD. M.,
GriebelP. J.2001b; Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifs. Cellular Immunology 214:155–164
van Drunen Littel-van den HurkS.,
van den HurkJ. V.,
GilchristJ. E.,
MisraV.,
BabiukL. A.1984; Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135:466–479
van Drunen Littel-van den HurkS.,
GiffordG. A.,
BabiukL. A.1990; Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8:358–368
van Drunen Littel-van den HurkS.,
ParkerM. D.,
MassieB.,
van den HurkJ. V.,
HarlandR.,
BabiukL. A.,
ZambT. J.1993; Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11:25–35
van Drunen Littel-van den HurkS.,
van DonkersgoedJ.,
KowalskiJ.,
van den HurkJ. V.,
HarlandR.,
BabiukL. A.,
ZambT. J.1994; A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12:1295–1302
van Drunen Littel-van den HurkS.,
TikooS. K.,
van den HurkJ. V.,
BabiukL. A.,
van DonkersgoedJ.1997; Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines. Vaccine 15:36–44
van Drunen Littel-van den HurkS.,
BraunR.,
LewisP.,
KarvonenB.,
Baca-EstradaM.,
SniderM.,
McCartneyD.,
WattsT.,
BabiukL.1998; Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. Journal of General Virology 79:831–839
van Drunen Littel-van den HurkS.,
BraunR. P.,
KarvonenB. C.,
KingT.,
YooD.,
BabiukL. A.1999; Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. Virology 260:35–46
van Drunen Littel-van den HurkS.,
GerdtsV.,
LoehrB. I.,
PontarolloR.,
RankinR.,
UwieraR.,
BabiukL. A.2000; Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Advanced Drug Delivery Reviews 43:13–28
van Drunen Littel-van den HurkS.,
LoehrB. I.,
BabiukL. A.2001; Immunization of livestock with DNA vaccines: current studies and future prospects. Vaccine 19:2474–2479
WhitbeckJ. C.,
KnappA. C.,
EnquistL. W.,
LawrenceW. C.,
BelloL. J.1996; Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins. Journal of Virology 70:7878–7884
YatesW. D.1982; A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral–bacterial synergism in respiratory disease of cattle. Canadian Journal of Comparative Medicine 46:225–263